Published on 20 Apr 2022 on Reuters
KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health
If successful, the takeover would rank as the biggest private equity-backed buyout of an Australian...
European Stocks Rise as Valuations Outweigh ECB Policy Concerns
(Bloomberg) -- European equities gained as enticing valuations outweighed concerns about tighter ...
KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health
If successful, the takeover would rank as the biggest private equity-backed buyout of an Australi...
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical...
Here's a roundup of top developments in the biotech space over the last 24 hours. Kodiak's Wet AM...
Credit Suisse Set to Name David Wah, Jens Welter as Co-Heads of Banking in Promotions
(Bloomberg) -- Credit Suisse Group AG has promoted investment bankers within its senior ranks as ...
Bankers Weigh What’s Next After Historic $5 Trillion M&A Record
(Bloomberg) -- The biggest mergers and acquisition boom in history isn’t showing signs of slowing...
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
Australian biopharma CSL Ltd (OTC: CSLLY) has agreed to acquire Vifor Pharma AG (OTC: GNHAY) for ...
Australian Shares Extend Declines, CSL Dips 8.2%
Australian Shares Extend Declines, CSL Dips 8.2%
ASX Trades Lower as Fed Flags Multiple Rate Hikes for 2022
ASX Trades Lower as Fed Flags Multiple Rate Hikes for 2022
Do Institutions Own Cara Therapeutics, Inc. (NASDAQ:CARA) Shares?
If you want to know who really controls Cara Therapeutics, Inc. (NASDAQ:CARA), then you'll have t...
Australia’s CSL to Buy Drugmaker Vifor for $11.7 Billion
(Bloomberg) -- Australian biotech company CSL Ltd. agreed to buy Swiss drugmaker Vifor Pharma AG ...